Projects funded by the NCN
Polymersomes specifically releasing cGAMP and doxorubicin in tumor hypoxic regions as a new anti-cancer therapeutic strategy
2020/39/B/NZ5/00745
Keywords:
Polymer drug nanocarriers anti-cancer therapy hypoxia polymersomes immunostimulation
Descriptors:
- NZ5_007:
- NZ7_014:
- NZ6_001:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy, Oddział w Gliwicach
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 20 - announced on 2020-09-15
Amount awarded: 1 433 426 PLN
Project start date (Y-m-d): 2021-09-30
Project end date (Y-m-d): 2025-09-29
Project duration:: 48 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapiesAuthors:Joanna Ciepła, Ryszard SmolarczykAcademic press:Clinical and Experimental Medicine (rok: 2024, tom: 24, strony: 235), Wydawca: SpringerStatus:PublishedDOI:10.1007/s10238-024-01501-1 - link to the publication